FEATURED NEWS

• HDA Statement on Department of Justice Opioid Efforts

  February 27, 2018

  Today, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to new efforts by the Department of Justice to address the opioid epidemic.

• HDA Calls for “Universal” Suspicious Orders Database to Enhance Efforts Against Diversion, Misuse

  February 22, 2018

  In a letter to the Drug Enforcement Administration (DEA) Acting Administrator Robert Patterson, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray called for a “universal” database to support enhanced monitoring of suspicious orders of controlled substances, including controlled opioid drugs. While the DEA has indicated that it currently is developing a suspicious orders database for its own use, HDA’s latest letter calls for the agency to share this data, and DEA’s advanced analytical tools, with state regulators and state/local law enforcement officials to improve information sharing and coordination.

• HDA Statement on New DEA Assessment Tool and Data

  February 15, 2018

  Following the Drug Enforcement Administration’s (DEA) announcement yesterday regarding a new assessment tool for controlled substance orders, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued the following statement.

• HDA Announces Availability of API Certification Program for Origin

  February 14, 2018

  The Healthcare Distribution Alliance (HDA) and ValueCentric today announced the introduction of a new certification program for third-party solution providers to exchange data with Origin on behalf of their manufacturer and distributor clients using an Application Programming Interface (API). Adents, a leading provider of premier and versatile serialization and track-and-trace solutions, is the first solution provider that has entered to meet the certification.

• Coalition of Public Health Organizations and Supply Chain Partners Launch Educational Initiative to Reduce Opioid Abuse and Misuse

  February 6, 2018

  Today, leading partners across healthcare, public health and the pharmaceutical supply chain joined together to launch Allied Against Opioid Abuse (AAOA), a national education and awareness initiative to help combat the nation’s opioid abuse epidemic.